SCHEMBL4647930

SCHEMBL4647930

O=S(=O)(O)c1cc(-c2cccc(Cl)c2)cc2c1OCC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 1/20 0.40
PARP10 Q53GL7 1/20 0.39
PARP11 Q9NR21 1/20 0.39
PGR P06401 1/20 0.37
TDP2 O95551 1/20 0.36
ALOX5 P09917 1/20 0.36
PARP1 P09874 1/20 0.35
PTGES2 Q9H7Z7 1/20 0.35
NRP1 O14786 3/20 0.34
PTGER2 P43116 1/20 0.34
DCLRE1B Q9H816 1/20 0.34
IKBKB O14920 1/20 0.34
CHUK O15111 1/20 0.34
FABP4 P15090 1/20 0.34
USP30 Q70CQ3 1/20 0.34
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
KAT6A Q92794 1/20 0.33
HSD17B3 P37058 1/20 0.33
ESR2 Q92731 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4648162 0.88 NRP1 (0.40) PARP1PTGES2NRP1HSD17B3
SCHEMBL4645575 0.86 MAPT (0.38) TDP2PARP1NRP1IKBKBCHUK
SCHEMBL4647649 0.86 ALDH1A1 (0.39) TDP2PARP1PTGES2NRP1
SCHEMBL4648561 0.86 PTPN1 (0.40) PDE4BPARP10PARP11PARP1PTGES2
SCHEMBL4648893 0.84 NRP1 (0.40) PTGES2NRP1IKBKBCHUKFABP4
SCHEMBL4648907 0.83 HDAC4 (0.40) ALOX5PTGES2KAT6AHSD17B3
SCHEMBL4648526 0.83 XDH (0.39) PGRPTGES2IKBKBCHUKUSP30
SCHEMBL4647082 0.83 MAPT (0.44) PARP10PARP11PGRPTGES2
SCHEMBL4647650 0.83 PARP10 (0.43) PARP10PARP11PGRTDP2PARP1
SCHEMBL4649303 0.81 TDP2 (0.45) PGRTDP2IKBKBCHUKHSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 US claimed
WO-2008104597-A2 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 WO claimed
EP-1964834-A1 Sulphonyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 EP claimed
US-20080255117-A1 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-10-16 US disclosed
WO-2008104597-A2 SULFONYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-09-04 WO disclosed
EP-1964834-A1 Sulphonyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255117-A1 SULFONYLTRYPTOPHANOLS FSHR, NPY1R, GNRHR PDE4B 1797/4885PARP10 589/4885PARP11 835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.